Trademark Alertz ®
Search
Trademark
Owner
Trademark: ZILBRYSQ 2135424
Word
ZILBRYSQ
ID
2135424
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
25 September 2020
Registration Date
25 September 2020
Renewal Date
25 September 2030
Owner(s)
Ra Pharmaceuticals, Inc.
Service
Goods and Services:
Class 5
:
Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder
;
pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system
;
pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders
;
pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders
;
pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents.
Class 10
:
Syringes for injections
;
syringes for medical purposes
;
syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication.